Table 3 Clinicopathological factors and their relationship to the expression of different proteins, assessed in SCC cases
From: Prognostic significance of CD44s expression in resected non-small cell lung cancer
Characteristics | CD44s (n = 72) | COX-2 (n = 77) | ||
|---|---|---|---|---|
| Â | Low(%) | High(%) | Low(%) | High(%) |
Tumor differentiation | Â | Â | Â | Â |
   Well | 0(0) | 4(100) | 1(25.0) | 3(75.0) |
   Moderately, poorly | 6(8.8) | 62(91.2) | 22(30.1) | 51(69.9) |
p-value | Â | 0.701 | Â | 0.655 |
Tumor size | Â | Â | Â | Â |
   ≤ 3 cm | 1(5.6) | 17(94.4) | 6(30.0) | 14(70.0) |
   > 3 cm | 4(7.5) | 497(92.5) | 20(37.7) | 33(62.3) |
p-value | Â | 0.625 | Â | 0.976 |
Lymph node metastasis | Â | Â | Â | Â |
   N0-1 | 5(8.1) | 57(91.9) | 21(31.3) | 46(68.7) |
   N2-3 | 1(10.0) | 9(90.0) | 2(20.0) | 8(80.0) |
p-value | Â | 0.607 | Â | 0.373 |
Stage | Â | Â | Â | Â |
   I | 3(7.9) | 35(92.1) | 12(28.6) | 30(71.4) |
   II | 1(6.3) | 15(93.8) | 4(23.5) | 13(76.5) |
   III | 2(11.1) | 16(88.9) | 7(38.9) | 11(61.1) |
p-value | Â | 0.736 | Â | 0.594 |
Lymphatic invasion | Â | Â | Â | Â |
   negative | 5(13.2) | 33(86.8) | 11(27.5) | 29(72.5) |
   positive | 1(3.3) | 29(96.7) | 11(33.3) | 22(66.7) |
p-value | Â | 0.163 | Â | 0.589 |